Microvast’s (MVST) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Microvast (NASDAQ:MVSTFree Report) in a research note published on Monday morning,Benzinga reports. They currently have a $3.00 price objective on the stock.

Microvast Stock Down 13.3 %

NASDAQ:MVST opened at $0.62 on Monday. Microvast has a 12 month low of $0.15 and a 12 month high of $1.55. The firm has a fifty day simple moving average of $0.27 and a 200-day simple moving average of $0.34. The company has a current ratio of 1.30, a quick ratio of 0.83 and a debt-to-equity ratio of 0.24.

Institutional Investors Weigh In On Microvast

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Point72 DIFC Ltd purchased a new position in shares of Microvast during the second quarter worth $28,000. Keynote Financial Services LLC purchased a new position in Microvast in the first quarter valued at $40,000. AQR Capital Management LLC increased its holdings in Microvast by 569.1% in the second quarter. AQR Capital Management LLC now owns 109,139 shares of the company’s stock valued at $50,000 after buying an additional 92,828 shares in the last quarter. XTX Topco Ltd purchased a new position in Microvast in the second quarter valued at $80,000. Finally, Renaissance Technologies LLC purchased a new position in Microvast in the second quarter valued at $90,000. 20.72% of the stock is currently owned by institutional investors and hedge funds.

About Microvast

(Get Free Report)

Microvast Holdings, Inc provides battery technologies for electric vehicles and energy storage solutions. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, and nickel manganese cobalt version 1 and 2. It also designs, develops, and manufactures battery components, such as cathode, anode, electrolyte, and separator.

Recommended Stories

Receive News & Ratings for Microvast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microvast and related companies with MarketBeat.com's FREE daily email newsletter.